Related Experiment Video

Updated: Jul 4, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

[Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta]

T L Demina, N V Khachanova, M V Davydovskaia

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |June 24, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
    08:04

    Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

    Published on: July 9, 2014

    Related Concept Videos

    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

    Articles linked to this work by shared authors, journal, and citation graph.

    [Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Results of the implementation of reperfusion technologies in ischemic stroke].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

    [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

    [Severe acute poisoning with methadone and α-pyrrolidinovalerophenone complicated by circulatory arrest].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Influence of social networks on the formation of dysmorphophobia and the risk of developing eating disorders in students].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Healthy young adults with a family history of alcohol dependence: Suicidal ideation, anxiety, and «novelty-seeking»].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Ketogenic diet in the treatment of drug-resistant epilepsy in children: Assessment of clinical efficacy, health care resource consumption, and direct medical costs].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Clinical and functional characteristics of Parkinson's disease in patients with chronic kidney disease].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    [Factors associated with the progression of mild cognitive impairment in patients with atrial fibrillation].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026

    Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

    Diabetes, metabolic syndrome and obesity : targets and therapy·2026

    The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

    Case reports in immunology·2026

    Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

    Frontiers in immunology·2026

    Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

    Frontiers in immunology·2026

    Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency.

    Therapeutic advances in hematology·2026

    Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us